Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Breast Neoplasms × Ethanol × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Waldenstrom Macroglobulinemia 1 Thrombocythemia, Essential 1 Smoking Cessation 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pancreatic Neoplasms 1 Pancreatic Cyst 1 Neoplasms, Plasma Cell 1 Neoplasms, Cystic, Mucinous, and Serous 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Prolymphocytic 1

Interventions

Paclitaxel 24 Trastuzumab 19 Cyclophosphamide 16 Docetaxel 14 Doxorubicin 11 exemestane 10 Radiotherapy 10 Capecitabine 10 Letrozole 9 Carboplatin 9 Lapatinib 8 Fulvestrant 8 pembrolizumab 7 Goserelin 6 Anastrozole 6 palbociclib 5 eribulin 5 Therapeutics 5 Neoadjuvant Therapy 5 Chemotherapy, Adjuvant 5 Bevacizumab 5 Aromatase Inhibitors 5 tucatinib 4 abemaciclib 4 Vinorelbine 4 Taxes 4 Polymerase Chain Reaction 4 Mastectomy, Segmental 4 Magnetic Resonance Spectroscopy 4 Exercise 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04007549 2024-11-19

IBMC

Institut Bergonié

Phase NA Withdrawn

Alcohol Drinking, Breast Neoplasms, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡